{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:42:08Z","timestamp":1790883728933,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To analyze the recurrence features and prognostic factors of patients with intravenous leiomyomatosis after complete tumor resection.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>We conducted a retrospective study of 58 patients with intravenous leiomyomatosis with follow-up data out of 75 patients treated from September 2005 to September 2015 and an analysis of postoperative recurrence features and prognostic factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>The average patient age was 45.4 years. The preoperative diagnosis rate was low. Among the 58 total patients, 31 had tumors that spread to the inferior vena cava and heart. During the median follow-up of 11.5 months, recurrence occurred in 18 patients at a rate of 31.0% (95% confidence interval 19.0\u201343.0%). Recurrence was associated with the preoperative tumor extent, and large vein involvement (16\/31 compared with 2\/27,<jats:italic toggle=\"yes\">P<\/jats:italic>=.02) was a risk factor for postoperative recurrence. Postoperative recurrence was not associated with age (1\/10 in 50 years or older compared with 17\/48 younger than 50 years,<jats:italic toggle=\"yes\">P<\/jats:italic>=.35), involvement of the heart (10\/22 compared with 8\/36,<jats:italic toggle=\"yes\">P<\/jats:italic>=.28), resection of the uterus (16\/51 compared with 2\/7,<jats:italic toggle=\"yes\">P<\/jats:italic>=.84) or bilateral ovaries (15\/40 compared with 3\/18,<jats:italic toggle=\"yes\">P<\/jats:italic>=.65) with complete tumor removal, the choice of one-stage or two-stage surgery (11\/45 for one-stage surgery compared with 7\/13 for two-stage surgery,<jats:italic toggle=\"yes\">P<\/jats:italic>=.20), postoperative antiestrogen hormone therapy (10\/24 compared with 8\/34,<jats:italic toggle=\"yes\">P<\/jats:italic>=.53), or the hormone therapy duration (5\/17 in the over-6-months group compared with 13\/41 in the under-6-months group,<jats:italic toggle=\"yes\">P<\/jats:italic>=.81).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION:<\/jats:title><jats:p>The postoperative recurrence rate of intravenous leiomyomatosis was high, and large vein involvement was associated with an increased risk of recurrence. Continued postoperative follow-up is important. Neither resection of bilateral ovaries nor postoperative hormone therapy was associated with recurrence.<\/jats:p><\/jats:sec>","DOI":"10.1097\/aog.0000000000001718","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T12:15:01Z","timestamp":1476274501000},"page":"1018-1024","source":"Crossref","is-referenced-by-count":45,"title":["Factors Associated With Recurrence After Surgical Resection in Women With Intravenous Leiomyomatosis"],"prefix":"10.1097","volume":"128","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jvs.2003.08.012","article-title":"Intravenous leiomyomatosis: two cases with different routes of tumor extension","volume":"39","author":"Lam","year":"2004","journal-title":"J Vasc Surg"},{"key":"R2-20230711","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-211712","article-title":"Intravenous leiomyomatosis with intracardiac extension: an unusual presentation of uterine leiomyoma and evaluation with 256-slice dual-source multidetector CT and cardiac MRI","volume":"2015","author":"Jain","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.humpath.2010.10.015","article-title":"Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 18 cases, with emphasis on early diagnosis and appropriate treatment strategies","volume":"42","author":"Du","year":"2011","journal-title":"Hum Pathol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/AOG.0b013e31826ebb90","article-title":"Management of intravenous leiomyomatosis with intracaval and intracardiac extension","volume":"120","author":"Wang","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PGP.0000000000000127","article-title":"Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center","volume":"34","author":"Carr","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20230711","first-page":"1124","article-title":"Postmenopausal intravenous leiomyomatosis with high levels of estradiol and estrogen receptor","volume":"100","author":"Kokawa","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2013.09.031","article-title":"Update on intravenous leiomyomatosis: report of five patients and literature review","volume":"171","author":"Vald\u00e9s Devesa","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.0001-6349.2005.00707.x","article-title":"Increased hyaluronan and CD44 expressions in intravenous leiomyomatosis","volume":"84","author":"Chen","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R9-20230711","first-page":"362","article-title":"Estrogen and progesterone expression of vein walls with intravascular leiomyomatosis; discussion of histogenesis","volume":"25","author":"Kir","year":"2004","journal-title":"Eur J Gynaecol Oncol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.athoracsur.2012.02.019","article-title":"Pulmonary embolization as the primary clinical manifestation of intravenous leiomyomatosis with intracardiac extension","volume":"94","author":"Zhang","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1017\/S1047951115001407","article-title":"Orthostatic hypotension and right heart failure as the initial manifestation of intravenous leiomyomatosis","volume":"26","author":"Li","year":"2016","journal-title":"Cardiol Young"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jvs.2011.03.261","article-title":"Intravenous leiomyomatosis presenting as acute Budd-Chiari syndrome","volume":"54","author":"Barksdale","year":"2011","journal-title":"J Vasc Surg"},{"key":"R13-20230711","first-page":"73","article-title":"Intracardiac extension of intravenous leiomyomatosis in a pregnant woman: A case report and review of the literature","volume":"16","author":"Ling","year":"2000","journal-title":"Can J Cardiol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1148\/rg.287085095","article-title":"Leiomyomas beyond the uterus: unusual locations, rare manifestations","volume":"28","author":"Fasih","year":"2008","journal-title":"Radiographics"},{"key":"R15-20230711","first-page":"756141","article-title":"Treatment of intravenous leiomyomatosis with cardiac extension following incomplete resection","volume":"2015","author":"Doyle","year":"2015","journal-title":"Int J Vasc Med"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0020-7292(02)00336-3","article-title":"Intravenous leiomyomatosis extending to the heart","volume":"80","author":"Khayata","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"R17-20230711","first-page":"883","article-title":"GnRH agonist for intravenous leiomyomatosis with cardiac extension. A case report","volume":"44","author":"Mitsuhashi","year":"1999","journal-title":"J Reprod Med"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/icvts\/ivt117","article-title":"Intracardiac leiomyomatosis: a comprehensive analysis of 194 cases","volume":"17","author":"Li","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201611000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T07:51:02Z","timestamp":1749628262000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201611000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001718","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}